Dr Patrick Vallance

Patrick Vallance
Patrick Vallance

Dr Patrick Vallance - download image (JPG)

Patrick Vallance is President, R&D. Prior to this, he was Senior Vice President, Medicines Discovery and Development. Patrick joined the company in May 2006 as Head of Drug Discovery. He is a member of the Board and the Corporate Executive Team.

Prior to joining GSK, Patrick was a clinical academic and as Professor of Medicine led the Division of Medicine at University College London.

He has worked in clinical medicine, general internal medicine, cardiovascular medicine and clinical pharmacology for over 20 years. He has an international reputation as a vascular biologist and clinician scientist. His research has spanned structural and molecular studies, in vitro and in vivo experimental pharmacology and clinical studies including the use of large-scale patient databases. At GSK, he has transformed the discovery engine to focus on therapy areas that are underpinned by the most promising and mature science, and which offer fresh insights into diseases. He is also responsible for creating small, empowered research teams, called Discovery Performance Units. This approach has led to a new wave of medicines for diseases from malaria through to cancer treatments. He has championed open innovation and transparency of clinical trial results.

He was elected to the Academy of Medical Sciences in 1999 and subsequently became its Registrar before leaving to join GSK. He is a non-executive director of Genome Research Limited and UK Biobank.